Literature DB >> 10331587

Molecular screening of fragile X (FRAXA) and FRAXE mental retardation syndromes in the Hellenic population of Greece and Cyprus: incidence, genetic variation, and stability.

P C Patsalis1, C Sismani, J A Hettinger, I Boumba, I Georgiou, G Stylianidou, V Anastasiadou, R Koukoulli, G Pagoulatos, M Syrrou.   

Abstract

This study presents the first large, population-based molecular investigation of the fragile X (FRAXA) and FRAXE mental retardation syndromes in the Hellenic populations of Greece and Cyprus. The aims of this population screening were to determine the prevalence of FRAXA and FRAXE syndromes among idiopathic mentally retarded (IMR) individuals, to estimate the incidence in the general population, and to investigate the molecular mechanism of instability and expansion of the FMR1-repeat. Ten FRAXA patients were identified to have either the full mutation (eight) or premutation (two) from a Hellenic population of 866 unrelated IMR individuals (611 males and 255 females, age range 3-25 years). No FRAXE patients were identified among the 611 IMR males. The incidence of FRAXA in the Hellenic population of Cyprus is estimated at 1 in 4,246 males. The repeat sites from the FMR1 and FMR2 alleles were accurately determined and showed similar distribution and frequencies with other population studies. The analysis of AGG interspersion within the FMR1-repeat in normal males revealed long, pure CGG repeats within the "gray zone" as well as variation within the 3' end showing polarity of instability. This finding supports the hypothesis that the AGG interspersion and the length of the pure repeat are major factors in determining allele stability. Analysis of FRAXAC1, DXS548, and FRAXAC2 identified particular alleles and haplotypes to have a significant association with either gray zone alleles or alleles >15 pure CGG repeats. We hypothesize that this subgroup of alleles and haplotypes are associated with long pure CGGs (>15 CGG) or 35 repeats and, having shared an evolutionary past, would have the tendency to expand.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10331587

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  13 in total

1.  FMR1 haplotype analyses among Indians: a weak founder effect and other findings.

Authors:  Deepti Sharma; Meena Gupta; B K Thelma
Journal:  Hum Genet       Date:  2002-12-14       Impact factor: 4.132

Review 2.  X linked mental retardation: a clinical guide.

Authors:  F L Raymond
Journal:  J Med Genet       Date:  2005-08-23       Impact factor: 6.318

3.  Genetic diversity of the fragile X syndrome gene (FMR1) in a large Sub-Saharan West African population.

Authors:  Emmanuel K Peprah; Emily G Allen; Scott M Williams; Laresa M Woodard; Stephanie L Sherman
Journal:  Ann Hum Genet       Date:  2010-07       Impact factor: 1.670

4.  FRAXA and FRAXE: the results of a five year survey.

Authors:  S A Youings; A Murray; N Dennis; S Ennis; C Lewis; N McKechnie; M Pound; A Sharrock; P Jacobs
Journal:  J Med Genet       Date:  2000-06       Impact factor: 6.318

Review 5.  Fragile X syndrome: the FMR1 CGG repeat distribution among world populations.

Authors:  Emmanuel Peprah
Journal:  Ann Hum Genet       Date:  2011-12-21       Impact factor: 1.670

6.  Identification of expanded alleles of the FMR1 Gene in the CHildhood Autism Risks from Genes and Environment (CHARGE) study.

Authors:  Flora Tassone; Nimrah S Choudhary; Federica Tassone; Blythe Durbin-Johnson; Robin Hansen; Irva Hertz-Picciotto; Isaac Pessah
Journal:  J Autism Dev Disord       Date:  2013-03

7.  Identification of novel FMR1 variants by massively parallel sequencing in developmentally delayed males.

Authors:  Stephen C Collins; Steven M Bray; Joshua A Suhl; David J Cutler; Bradford Coffee; Michael E Zwick; Stephen T Warren
Journal:  Am J Med Genet A       Date:  2010-10       Impact factor: 2.802

Review 8.  Post-translational modifications of the Fragile X Mental Retardation Protein in neuronal function and dysfunction.

Authors:  Marta Prieto; Alessandra Folci; Stéphane Martin
Journal:  Mol Psychiatry       Date:  2019-12-10       Impact factor: 15.992

9.  Screening for expanded alleles of the FMR1 gene in blood spots from newborn males in a Spanish population.

Authors:  Isabel Fernandez-Carvajal; Paulina Walichiewicz; Xie Xiaosen; Ruiqin Pan; Paul J Hagerman; Flora Tassone
Journal:  J Mol Diagn       Date:  2009-05-21       Impact factor: 5.568

Review 10.  FMR1 and the fragile X syndrome: human genome epidemiology review.

Authors:  D C Crawford; J M Acuña; S L Sherman
Journal:  Genet Med       Date:  2001 Sep-Oct       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.